Methods of adjustment of antipsychotic treatment of the needs of the individual patients with schizophrenia

被引：0
作者：
Potanin, S. S. [1 ]
Burminsky, D. S. [1 ]
Morozova, M. A. [1 ]
机构：
[1] Russian Acad Med Sci, Mental Hlth Res Ctr, Moscow 109801, Russia
来源：
ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 2013年 / 113卷 / 10期
关键词：
schizophrenia; individualization of antipsychotic treatment; pharmacokinetic parameters; selection of antipsychotic drug; TREATMENT-RESISTANT SCHIZOPHRENIA; CLINICALLY IMPORTANT DIFFERENCES; COMBINED PHENOTYPIC ASSESSMENT; RANDOMIZED CONTROLLED-TRIAL; DRUG-METABOLIZING-ENZYMES; QUALITY-OF-LIFE; 1A2; CYP1A2; GENE; CYTOCHROME-P450; MONOZYGOTIC TWINS; ATYPICAL ANTIPSYCHOTICS;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：80 / 87
页数：8
相关论文
共 123 条
  • [1] Cytochrome P450 gene polymorphism and cancer
    Agúndez, JAG
    [J]. CURRENT DRUG METABOLISM, 2004, 5 (03) : 211 - 224
  • [2] PREVALENCE OF CYP2D6 GENE DUPLICATION AND ITS REPERCUSSION ON THE OXIDATIVE PHENOTYPE IN A WHITE-POPULATION
    AGUNDEZ, JAG
    LEDESMA, MC
    LADERO, JM
    BENITEZ, J
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (03) : 265 - 269
  • [3] Relapse in schizophrenia: costs, clinical outcomes and quality of life
    Almond, S
    Knapp, M
    Francois, C
    Toumi, M
    Brugha, T
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2004, 184 : 346 - 351
  • [4] CLOZAPINE-INDUCED AGRANULOCYTOSIS - INCIDENCE AND RISK-FACTORS IN THE UNITED-STATES
    ALVIR, JMJ
    LIEBERMAN, JA
    SAFFERMAN, AZ
    SCHWIMMER, JL
    SCHAAF, JA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (03) : 162 - 167
  • [5] [Anonymous], 1992, NURSE PRACT, DOI DOI 10.1097/00006205-199211000-00018
  • [6] [Anonymous], 1985, CLIN PSYCHIAT 2, V46, P22
  • [7] [Anonymous], 2013, CURR PHARM DES
  • [8] [Anonymous], 2011, PERS MED, V4, P123
  • [9] [Anonymous], 2011, EUR PSYCHIAT, V26, P3
  • [10] [Anonymous], 1999, THER DRUG MONIT, V21, P474
12345678910